Explain this page
Arphra AIPlain-English read on Pfizer Inc.’s valuationRatios & metrics
Profitability, returns on capital, growth, and credit — all derived from the historical income statement, balance sheet, and cash flow rows in our data warehouse.
Quality composite
BMixed
A snapshot of the latest fiscal year’s margins, returns on capital, balance-sheet strength and efficiency, computed from the income statement, balance sheet and cash-flow rows. Source income / balance / cash_flow.
Profitability
Gross margin70.3%
Operating margin24.7%
Net margin12.4%
ROE9.0%
ROA3.7%
ROIC10.4%
Liquidity & leverage
Current ratio1.16×
Quick ratio0.87×
Debt / equity0.78×
Net debt / EBITDA4.39×
Interest coverage6×
Efficiency & per-share
Asset turnover0.30×
Inventory days209
Days sales out.69
FCF / share$1.60
Book value / share$15.26
Valuation multiples
Price- and EV-based multiples plus shareholder yields. Snapshot at each fiscal year-end from key_metrics (FMP).
ActualEstimate
| In USD | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | 2026E | 2027E | 2028E | 2029E |
|---|---|---|---|---|---|---|---|---|---|
| Headline | |||||||||
| Market cap | — | — | — | $150.27B | $141.5B | — | — | — | — |
| Enterprise value | — | — | — | $216.22B | $207.77B | — | — | — | — |
| Multiples | |||||||||
| P / E | — | — | — | — | — | — | — | — | — |
| P / B | — | — | — | — | — | — | — | — | — |
| EV / EBITDA | — | — | — | — | — | — | — | — | — |
| EV / Sales | — | — | — | 3.40 | 3.32 | — | — | — | — |
| EV / FCF | — | — | — | 21.98 | 22.89 | — | — | — | — |
| Yields | |||||||||
| Earnings yield | — | — | — | +5.34% | +5.49% | — | — | — | — |
| Free cash flow yield | — | — | — | +6.55% | +6.41% | — | — | — | — |
| Dividend yield | — | — | — | — | — | — | — | — | — |
Profitability
Margin structure across the last 5 fiscal years
ActualEstimate
| In USD | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | 2026E | 2027E | 2028E | 2029E |
|---|---|---|---|---|---|---|---|---|---|
| Margins | |||||||||
| Gross margin | +57.67% | +61.89% | +50.95% | +65.77% | +70.33% | +63.35% | +63.39% | +62.57% | +60.71% |
| Operating margin | +25.58% | +37.43% | +8.89% | +25.91% | +24.67% | +20.41% | +19.48% | +20.41% | +19.79% |
| EBITDA margin | +37.88% | +40.90% | +16.05% | +28.49% | +24.12% | +22.57% | +22.48% | +22.76% | +22.51% |
| EBIT margin | +31.50% | +35.85% | +5.49% | +17.47% | +16.29% | +13.25% | +12.98% | +13.11% | +13.38% |
| Pre-tax margin | +29.91% | +34.61% | +1.78% | +12.61% | +12.02% | +8.82% | +8.80% | +8.81% | +8.81% |
| Net margin | +27.25% | +31.26% | +3.58% | +12.60% | +12.42% | +9.29% | +9.64% | +9.55% | +9.80% |
| Cost structure | |||||||||
| Cost of revenue / sales | +42.33% | +38.11% | +49.05% | +34.23% | +29.67% | +38.49% | +38.15% | +38.66% | +38.75% |
| R&D intensity | +17.01% | +11.39% | +17.76% | +16.88% | +19.14% | +17.63% | +17.62% | +17.40% | +18.16% |
| SG&A intensity | +15.07% | +13.07% | +24.30% | +23.15% | +21.33% | +22.98% | +22.33% | +22.69% | +23.19% |
| Effective tax rate | +7.62% | +9.58% | -105.29% | -0.35% | -3.54% | -1.91% | -1.96% | -1.94% | -1.97% |
Returns on capital
ROE / ROA / ROC / ROIC over the relevant capital base, plus the 3-step DuPont decomposition of ROE.
ActualEstimate
| In USD | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | 2026E | 2027E | 2028E | 2029E |
|---|---|---|---|---|---|---|---|---|---|
| Returns | |||||||||
| Return on equity (ROE) | +28.59% | +32.70% | +2.39% | +9.06% | +8.95% | +6.51% | +6.92% | +6.53% | +6.67% |
| Return on assets (ROA) | +12.20% | +15.90% | +0.94% | +3.76% | +3.73% | +2.59% | +2.76% | +2.77% | +2.84% |
| Return on capital (ROC) | +18.17% | +28.71% | +3.30% | +10.60% | +10.01% | +8.13% | +7.69% | +8.02% | +7.68% |
| Return on invested capital (ROIC) | +19.35% | +23.98% | +1.33% | +5.16% | +5.04% | +3.70% | +3.81% | +3.75% | +3.80% |
| Asset turnover | +44.79% | +50.88% | +26.29% | +29.82% | +30.06% | +27.86% | +28.62% | +28.95% | +28.98% |
| DuPont · ROE decomposition | |||||||||
| Net margin | +27.25% | +31.26% | +3.58% | +12.60% | +12.42% | +9.29% | +9.64% | +9.55% | +9.80% |
| Asset turnover (× revenue / assets) | +44.79% | +50.88% | +26.29% | +29.82% | +30.06% | +27.86% | +28.62% | +28.95% | +28.98% |
| Equity multiplier (× assets / equity) | +234.28% | +205.60% | +253.67% | +241.13% | +239.88% | +251.21% | +250.74% | +236.04% | +234.81% |
Activity & efficiency
Turnover ratios and days-outstanding — how efficiently the business converts assets and working capital into sales and cash.
ActualEstimate
| In USD | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | 2026E | 2027E | 2028E | 2029E |
|---|---|---|---|---|---|---|---|---|---|
| Turnover | |||||||||
| Asset turnover | 0.45 | 0.51 | 0.26 | 0.30 | 0.30 | 0.28 | 0.29 | 0.29 | 0.29 |
| Fixed-asset turnover | 5.46 | 6.17 | 3.14 | 3.46 | 2.91 | — | — | — | — |
| Inventory turnover | 3.80 | 4.26 | 2.87 | 2.01 | 1.74 | — | — | — | — |
| Receivables turnover | 5.16 | 6.91 | 3.83 | 4.31 | 5.27 | — | — | — | — |
| Payables turnover | 6.17 | 5.62 | 4.35 | 3.87 | 3.54 | — | — | — | — |
| Days outstanding | |||||||||
| Days sales outstanding (DSO) | 70.70 | 52.86 | 95.27 | 84.77 | 69.26 | — | — | — | — |
| Days inventory outstanding (DIO) | 96.08 | 85.72 | 127.31 | 181.84 | 209.46 | — | — | — | — |
| Days payables outstanding (DPO) | 59.16 | 64.99 | 83.84 | 94.40 | 103.02 | — | — | — | — |
| Cash conversion cycle | 107.62 | 73.59 | 138.74 | 172.21 | 175.70 | — | — | — | — |
Cash flow quality
How well reported earnings translate into operating and free cash flow, plus reinvestment intensity.
ActualEstimate
| In USD | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | 2026E | 2027E | 2028E | 2029E |
|---|---|---|---|---|---|---|---|---|---|
| Operating CF / Net income | 1.47 | 0.93 | 4.08 | 1.59 | 1.51 | 1.93 | 1.83 | 1.88 | 1.81 |
| FCF / Net income | 1.35 | 0.83 | 2.25 | 1.23 | 1.17 | 1.40 | 1.30 | 1.31 | 1.31 |
| FCF margin | +36.74% | +25.95% | +8.05% | +15.46% | +14.50% | +13.02% | +12.55% | +12.54% | +12.84% |
| OCF margin | +40.08% | +29.17% | +14.61% | +20.03% | +18.70% | +17.94% | +17.65% | +17.98% | +17.75% |
| CapEx / Revenue | +3.34% | +3.23% | +6.56% | +4.57% | +4.20% | +5.15% | +5.05% | +5.16% | +5.05% |
| CapEx / D&A | 0.52 | 0.64 | 0.62 | 0.41 | 0.40 | — | — | — | — |
| Stock-based comp / Revenue | +1.45% | +0.87% | +0.88% | +1.38% | 0.00% | — | — | — | — |
Per-share & shareholder yield
EPS, book value, sales, cash flow and dividends per share — plus payout / retention.
ActualEstimate
| In USD | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | 2026E | 2027E | 2028E | 2029E |
|---|---|---|---|---|---|---|---|---|---|
| EPS · diluted | 3.88 | 5.47 | 0.37 | 1.41 | 1.36 | 2.96 | 2.82 | 2.43 | 2.27 |
| EPS · basic | 3.95 | 5.59 | 0.38 | 1.42 | 1.36 | 2.94 | 2.84 | 2.46 | 2.30 |
| Book value / share | 13.57 | 16.73 | 15.64 | 15.53 | 15.26 | 15.39 | 14.38 | 13.98 | 13.64 |
| Tangible BV / share | 0.54 | 0.20 | -7.60 | -6.22 | -6.72 | 15.39 | 14.38 | 13.98 | 13.64 |
| Sales / share | 14.24 | 17.50 | 10.43 | 11.16 | 11.01 | 10.77 | 10.32 | 9.55 | 9.28 |
| Operating CF / share | 5.71 | 5.11 | 1.52 | 2.24 | 2.06 | 1.93 | 1.82 | 1.72 | 1.65 |
| Free cash flow / share | 5.23 | 4.54 | 0.84 | 1.73 | 1.60 | 1.40 | 1.30 | 1.20 | 1.19 |
| Dividends / share | 1.53 | 1.57 | 1.62 | 1.67 | 1.72 | 1.63 | 1.63 | 1.51 | 1.46 |
| Payout ratio | +39.41% | +28.64% | +433.52% | +118.60% | +125.75% | +163.01% | +163.78% | +165.14% | +160.11% |
| Retention ratio | +60.59% | +71.36% | -333.52% | -18.60% | -25.75% | -63.01% | -63.78% | -65.14% | -60.11% |
Growth
Year-over-year change for headline P&L lines, plus through-cycle CAGR
ActualEstimate
| In USD | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | 2026E | 2027E | 2028E | 2029E | 8y CAGR |
|---|---|---|---|---|---|---|---|---|---|---|
| Top-line | ||||||||||
| Revenue · YoY | — | +23.43% | -40.64% | +6.84% | -1.65% | -1.34% | -4.11% | -7.53% | -3.39% | -5.23% |
| Gross profit · YoY | — | +32.46% | -51.14% | +37.92% | +5.18% | -11.14% | -4.05% | -8.73% | -6.26% | -4.62% |
| Profit | ||||||||||
| Operating income · YoY | — | +80.58% | -85.91% | +211.47% | -6.35% | -18.38% | -8.47% | -3.12% | -6.33% | -8.22% |
| EBITDA · YoY | — | +33.25% | -76.71% | +89.67% | -16.72% | -7.70% | -4.49% | -6.35% | -4.48% | -11.20% |
| Net income · YoY | — | +41.62% | -93.20% | +276.00% | -3.12% | -26.14% | -0.56% | -8.35% | -0.88% | -16.60% |
| Operating | ||||||||||
| EBIT · YoY | — | +40.49% | -90.92% | +240.19% | -8.30% | -19.70% | -6.07% | -6.59% | -1.41% | -14.84% |
| R&D · YoY | — | -17.37% | -7.42% | +1.51% | +11.53% | -9.14% | -4.11% | -8.72% | +0.83% | -4.46% |
| Per-share | ||||||||||
| EPS · diluted · YoY | — | +41.01% | -93.22% | +279.85% | -3.55% | +117.52% | -4.55% | -13.97% | -6.66% | -6.49% |
| EPS · basic · YoY | — | +41.45% | -93.29% | +278.16% | -4.23% | +116.01% | -3.18% | -13.60% | -6.32% | -6.54% |
Credit & leverage
Balance-sheet health + interest coverage + liquidity. Coverage ratios use period-end debt and trailing interest expense.
ActualEstimate
| In USD | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | 2026E | 2027E | 2028E | 2029E |
|---|---|---|---|---|---|---|---|---|---|
| Leverage | |||||||||
| Total debt | $37B | $34.86B | $70.85B | $66.99B | $67.42B | $66.67B | $67.45B | $59.25B | $58.62B |
| Net debt | $35.05B | $34.44B | $67.99B | $65.95B | $66.27B | $64.95B | $65.83B | $57.76B | $57.17B |
| Net debt / EBITDA | 1.14 | 0.84 | 7.11 | 3.64 | 4.39 | 4.66 | 4.95 | 4.63 | 4.80 |
| Debt / equity | 0.48 | 0.36 | 0.79 | 0.76 | 0.78 | 0.76 | 0.82 | 0.74 | 0.75 |
| Debt / assets | +20.39% | +17.68% | +31.28% | +31.39% | +32.39% | +30.09% | +32.61% | +31.33% | +32.12% |
| Equity / assets | +42.68% | +48.64% | +39.42% | +41.47% | +41.69% | +39.81% | +39.88% | +42.36% | +42.59% |
| Coverage | |||||||||
| EBITDA / interest expense | 23.85 | 33.14 | 4.33 | 5.86 | 5.65 | 5.35 | 5.19 | 5.45 | 5.11 |
| Operating income / interest | 16.11 | 30.33 | 2.40 | 5.33 | 5.78 | 4.83 | 4.49 | 4.89 | 4.49 |
| Interest expense | $1.29B | $1.24B | $2.21B | $3.09B | $2.67B | $2.61B | $2.57B | $2.29B | $2.33B |
| Liquidity | |||||||||
| Current ratio | 1.40 | 1.22 | 0.91 | 1.17 | 1.16 | — | — | — | — |
| Quick ratio | 1.10 | 0.88 | 0.59 | 0.82 | 0.69 | — | — | — | — |
| Cash ratio | 0.05 | 0.01 | 0.06 | 0.02 | 0.03 | — | — | — | — |
| Working capital | $17.02B | $9.12B | -$4.46B | $7.36B | $5.91B | — | — | — | — |
| Working capital / revenue | +20.94% | +9.09% | -7.49% | +11.57% | +9.45% | — | — | — | — |
Sourced from key_metrics + financial_ratios (loaded by load_fundamentals_extended.py).
Valuation
| Metric | FY 2025 | FY 2024 |
|---|---|---|
| P / E | — | — |
| P / B | — | — |
| EV / EBITDA | — | — |
| EV / Sales | 3.32x | 3.40x |
| Earnings yield | 5.5% | 5.3% |
| FCF yield | 6.4% | 6.5% |
Returns
| Metric | FY 2025 | FY 2024 |
|---|---|---|
| Gross margin | — | — |
| Operating margin | — | — |
| Net margin | — | — |
| ROE | 9.0% | 9.1% |
| ROA | 3.7% | 3.8% |
| ROIC | 8.8% | 9.3% |
Leverage & liquidity
| Metric | FY 2025 | FY 2024 |
|---|---|---|
| Debt / equity | — | — |
| Net debt / EBITDA | 4.39 | 3.64 |
| Interest coverage | — | — |
| Current ratio | 1.16x | 1.17x |
| Quick ratio | — | — |
Methodology. ROE / ROA / ROC use period-end balance-sheet denominators (no average-of- period smoothing). ROIC = Operating Income × (1 − inferred effective tax rate) over invested capital, with the effective tax inferred from net-to-operating income when both are positive and a 25% default otherwise. Net debt / EBITDA, debt ratios, and interest-coverage ratios are calculated point-in-time at each fiscal year-end. TTM = trailing 4 quarters (income / cash flow summed, balance sheet = most-recent quarterly snapshot). Through-cycle CAGR in the Growth panel uses the geometric mean of first-to-last period growth across the window (positive values only).